Plasma citrulline concentration - A reliable noninvasive marker of functional enterocyte mass;Hladina plazmatického citrulinuspolehlivý neinvazivní ukazatel množství funkčních enterocytů

Casopis Lekaru Ceskych

Volumn 149, Issue 4, 2010, Pages 160-162

  Oliverius, Martin ^a   Kudla, Michal ^a   Baláž, Peter ^a   Valsamis, Alexandros ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Bowel transplantation; Citrulline; Intestinal failure

Indexed keywords

BIOLOGICAL MARKER; CITRULLINE;

BLOOD; ENTEROPATHY; GRAFT REJECTION; HUMAN; INTESTINE CELL; METABOLISM; PATHOLOGY; REVIEW; SHORT BOWEL SYNDROME; SMALL INTESTINE; TRANSPLANTATION;

BIOLOGICAL MARKERS; CITRULLINE; ENTEROCYTES; GRAFT REJECTION; HUMANS; INTESTINAL DISEASES; INTESTINE, SMALL; SHORT BOWEL SYNDROME;

EID: 77951836554     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr 2008; 27: 328-339.
2. Schellekens GA, de Jong BA, van den Hoogen FH, van den Putte LB, van Venrooij WJ. Citrulline is an Essentials konstituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-281.
3. 3. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology 2000; 119: 1496-1505. (Pubitemid 32198675)
4. 4. Papadia C, Sherwood RA, Kalantzis C, Wallis K, Volta U, Fiorini E, et al. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation. Am J Gastroentrol 2007; 102: 1474-1482. (Pubitemid 46976295)
5. Kabrt J, Hyanek J, Stastna S, Pospisilova E. Plasma citruline concentration is a marker of small intestine failure. Biomed Papers 2003; 146(1): 75.
6. Dowling RH. Cellular and molecular basis of intestinal and pancreatic adaptation Scandinavian J Gastroenterol 1992; 193(Suppl): 64-67.
7. Tappenden KA. Mechanisms of enteral nutriet-enhanced intestinal adaptation. Gastroenterology 2006; 130(Suppl 1): S93-S99.
8. Rhoads JM, Plunkett E, Galanko J, Lichtman S, Taylor L, Maynor A, Weiner T, Freeman K, Guarisco JL, Wu GY. Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome. J Pediatr 2005; 146: 542-547.
9. Andres AM, Thompson J, Grant W, Botha J, Sunderman B, Antonson D, Langnas A, Sudan D. Repeat surgical bowel lengthening with the STEP procedure. Transplantation 2008; 85: 1294-1299.
10. Sudan D, Thompson J, Botha J, Grant W, Antonson D, Raynor S, Langnas A. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg 2007; 246: 593-601.
11. Castanon M, Prat J, Saura L, Gomez L. Tarrado X, lriondo M, Morales L. Nutritional and surgical management of short bowel syndrome. Our last 6 patients' experience. Cir Pediatr 2006; 19: 151-155.
12. 12. Kim HB, Lee PW, Garza J, Duggan C, Fauza D, Jaksic T. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg 2003; 38: 881-885. (Pubitemid 36666282)
13. Chang RW, Javid PJ, Oh JT, Andreoli S, Kim HB, Fauza D, Jaksic T. Serial transverse enteroplasty enhances intestinal function in a model of short bowel syndrome. Ann Surg 2006; 243: 223-228.
14. Fryer JP. Intestinal transplantation: an update. Curr Opin Gastroenterol 2005; 21: 162.
15. Ischii T, Mazariegos GV, Bueno J, Ohwada S, Reyes J. Exfoliative rejection after intestinal transplntation in children. Pediatr Transplant 2003; 7: 185.
16. Sudan DL, Kaufmann SS, Shaw BW Jr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000; 95: 1506.
17. David Al, Selvaggi G, Ruiz P, Gaynor JJ, Tryphonopoulos P, Kleiner Gl, Moon Jl, Nishida S, Pappas PA, Conanan L, Weppler D, Esquenazi V, Levi DM, Kato T, Tzakis AG. Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation. Transplantation 2007; 84: 1077-1081.
18. Gondolesi GE, Kaufman SS, Sansaricq C, Magid MS, Raymond K, lledan LP, Tao Y, Florman SS, LeLeiko NS, Fishbein TM. Defining normal plasma citrulline in intestinal transplant recipients. Am J Transplant 2004; 4: 414-418.
19. Dilloon L, Knabe D, Wu G. Lactate inhibits citruline and arginine synthesis from proline in pig enterocytes. Am J Physiol 1999; 276: G1079-G1086.
20. Gondolesi G, Ghirardo S, Raymond K, Hoppenhauer L, Surillo D, Rumbo c, Fisbein T, Sansaricq C, Sauter B. The value of plasma citruline to predict mucosal injury in intestinal transplantation. Am J Transplant 2006; 6: 2786-2790.
21. Yu HC, Tuteja S, Moon Jl, Kleiner Gl, Conanan L, Gaynor JJ, Kato T, Levi DM, Nishida S, Selvaggi G, Gandia C, Weppler D, Esquenazi V, Ruiz P, Miller J, Tzakis AG. Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation. Transplantation 2005; 80: 1729-1733.